This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Fisher, J. A. Articles by Troxel, A. B. Search for Related Content PubMed PubMed Citation Articles by Fisher, J. A. Articles by Troxel, A. B.

Cutting Cost and Increasing Access to Colorectal Cancer Screening: Another Approach to Following the Guidelines

Departments of ¹ Family Practice and Community Medicine and ² Biostatistics and Epidemiology, University of Pennsylvania, School of Medicine, Philadelphia, Pennsylvania; and ³ The Boston Consulting Group, New York, New York

Requests for reprints: Judith A. Fisher, Department of Family Practice and Community Medicine, University of Pennsylvania, School of Medicine, 6th Floor Mutch Building, 39th and Market Streets, Philadelphia, PA 19104. Phone: 215-265-9601; Fax: 215-243-3290. E-mail: Judith.Fisher{at}uphs.upenn.edu.

Context: Through medical decision making, physicians in the U.S. influence the spending of >$1.3 trillion or 15% of the gross domestic product. U.S. physicians are challenged to identify areas of clinical practice to improve while cutting cost and increasing access. Primary screening for colorectal cancer is a good example to illustrate this point.

Objective: To apply a population-based method of medical decision making in the area of primary screening for colorectal cancer in order to illustrate a reduction in health care costs while increasing access and maintaining quality of care.

Design: We used a combination of (a) census population data, (b) National Cancer Institute Survey data on screening rates, and (c) charge data to estimate the current costs of colorectal cancer screening. We also estimated cost and capacity increases that would occur under various other screening scenarios. These included all currently screened subjects receiving annual fecal occult blood testing (FOBT), all currently unscreened individuals undergoing either colonoscopy every decade or annual FOBT, and all eligible subjects undergoing annual FOBT.

Main outcome measures: Cost and access differences between current screening activity and other potential scenarios compliant with guidelines.

Results: Screening for colorectal cancer with yearly, six-window, rehydrated FOBT for all normal-risk individuals over the age of 50 has the potential to screen 3,813,095 more Americans for colon cancer yearly than are currently being screened, while costing $8.7 billion less per decade than what is currently being spent on screening a fraction of the population. Looking into the future, it is possible to increase screening rates from 50% to 100%, while saving almost $10 billion per decade by using FOBT for all eligible Americans. In practice, some proportion of these benefits would be realized as the calculations assume a 100% patient compliance rate.

Conclusions: Considering a population-based approach and the balance among quality, accessibility, and cost parameters, we recommend primary screening for colorectal cancer to be based on yearly six-window, rehydrated FOBT. Colonoscopy due to cost and access issues should be relegated to secondary screening and case finding. (Cancer Epidemiol Biomarkers Prev 2006;15(1):108–13)

This article has been cited by other articles:

				A. E. Maxwell and C. M. Crespi Trends in Colorectal Cancer Screening Utilization among Ethnic Groups in California: Are We Closing the Gap? Cancer Epidemiol. Biomarkers Prev., March 1, 2009; 18(3): 752 - 759. [Abstract] [Full Text] [PDF]

				M. B. Potter, L. Phengrasamy, E. S. Hudes, S. J. McPhee, and J. M.E. Walsh Offering Annual Fecal Occult Blood Tests at Annual Flu Shot Clinics Increases Colorectal Cancer Screening Rates Ann. Fam. Med, January 1, 2009; 7(1): 17 - 23. [Abstract] [Full Text] [PDF]

				A. E. Maxwell, L. L. Danao, C. M. Crespi, C. Antonio, G. M. Garcia, and R. Bastani Disparities in the Receipt of Fecal Occult Blood Test versus Endoscopy among Filipino American Immigrants Cancer Epidemiol. Biomarkers Prev., August 1, 2008; 17(8): 1963 - 1967. [Abstract] [Full Text] [PDF]

				A. F. Jerant, J. J. Fenton, and P. Franks Determinants of Racial/Ethnic Colorectal Cancer Screening Disparities Arch Intern Med, June 23, 2008; 168(12): 1317 - 1324. [Abstract] [Full Text] [PDF]

				M. E. Pelleschi Clostridium difficile-Associated Disease: Diagnosis, Prevention, Treatment, and Nursing Care Crit. Care Nurse, February 1, 2008; 28(1): 27 - 35. [Full Text] [PDF]